Knowledge of the chronic urticaria between specialist physicians and residents of dermatology in Colombia: crosssectional study based on survey to a sample of physicians
DOI:
https://doi.org/10.29176/2590843X.427Keywords:
Urticaria, Colombia, surveys and questionnairesAbstract
Chronic urticaria (CU) is defined as a condition characterized by the appearance of wheals, angioedema or both, for a period greater than 6 weeks. The objective of this research was to identify the degree of knowledge about UC among medical specialists and residents of dermatology in Colombia, through a survey of 86 physicians. More than 90 % of the participants agreed with the proper definition of UC. Nearly 50 % of the specialists and two-thirds of residents consider the use of various tests as part of the diagnostic exercise, while most do not consider the routine use of biopsy. The impact of the disease on the quality of life is recognized by most of the participants. 50 % of the specialists do not use clinimetry tools and 50 % of the residents do not know them. This is the first study that explores the knowledge of UC among dermatologists in Colombia and exposes opportunities for improvement in clinical practice in accordance with the recommendations of the current international guidelines.
Author Biographies
Natalia Hernández
Médica, especialista en Dermatología, Alergias Cutáneas y Dermatología genital. Dermatología Ocupacional. Magíster en Economía de la Salud y del Medicamento
Diana Carolina Tamayo
Médica, magíster en Epidemiología Clínica. Médica de enlace científico en dermatología, para Novartis de Colombia
References
Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of ur¬ticaria. Allergy. 2018;73(7):1393-414. doi: 10.1111/all.13397.
https://doi.org/10.1111/all.13397
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69(7):868-87. doi: 10.1111/all.12313.
https://doi.org/10.1111/all.12313
Rimoldi M, Rossi O, Rota N. State of the art of chronic spontaneous urticaria in Italy: a multi¬centre survey to evaluate physicians' and patients' perspectives. BMJ Open. 2016;6(10):e012378. doi: 10.1136/bmjopen-2016-012378.
https://doi.org/10.1136/bmjopen-2016-012378
Sanclemente G, Mahecha M, Guzmán C. Enfer¬medades de la piel más frecuentes en la consulta externa dermatológica del Hospital Universitario San Vicente de Paúl y del Hospital Infantil. Mede¬llín, 1999. Acta Med Colomb. 2001;26(5):240-44.
Gaig P, Olona M, Muñoz Lejarazu D, Caballero MT, Domínguez FJ, Echechipia S, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Im¬munol. 2004;14(3):214-20.
Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a represen¬tative cross-sectional population survey. Clin Exp Dermatol. 2010;35(8):869-73. doi: 10.1111/j.1365-2230.2010.03840.x.
https://doi.org/10.1111/j.1365-2230.2010.03840.x
Furue M, Yamazaki S, Jimbow K, Tsuchida T, Amagai M, Tanaka T, et al. Prevalence of der¬matological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study. J Dermatol. 2011;38(4):310-20. doi: 10.1111/j.1346-8138.2011.01209.x.
https://doi.org/10.1111/j.1346-8138.2011.01209.x
Calderón JC, Chérrez Ojeda I, Weller K, Maurer M, Chérrez A. Management of chronic urticaria in real life: cross-sectional physical-based survey study in Latin-America. Allergy. 2016;(Suppl. 102):528-91. Poster 1253.
Valero A, Herdman M, Bartra J, Ferrer M, Jáuregui I, Dávila I, et al. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). J Investig Allergol Clin Immunol. 2008;18(6):426-32.
Balañá M, Valero A, Giménez Arnau A, Ferrer M, Jauregui I, Ballesteros C, et al. Validation of The Spanish Version of The Urticaria Activity Score (Uas) and Its Use Over One Week (Uas7). Value Health. 2015;18(7):A426. doi: 10.1016/j.jval.2015.09.584.
https://doi.org/10.1016/j.jval.2015.09.584
García-Díez I, Curto-Barredo L, Weller K, Pujol RM, Maurer M, Giménez-Arnau AM. Cross-Cultural Adaptation of the Urticaria Control Test From German to Castilian Spanish. Actas Dermosifiliogr. 2015;106(9):746-52. doi: 10.1016/j.ad.2015.05.009.
https://doi.org/10.1016/j.ad.2015.05.009
Maurer M, Staubach P, Raap U, Richter-Huhn G, Bauer A, Ruëff F, et al. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study. Clin Exp Allergy. 2017;47(5):684-92. doi: 10.1111/cea.12900.
https://doi.org/10.1111/cea.12900
Saini SS, Bindslev-Jensen C, Maurer M, Grob JJ, Bülbül Baskan E, Bradley MS, et al. Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J Invest Dermatol. 2015;135(1):67-75. doi: 10.1038/jid.2014.306.
https://doi.org/10.1038/jid.2014.306
Maurer M, Rosén K, Hsieh HJ, Saini S, Grattan C, Gimenéz-Arnau A, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368(10):924-35. doi: 10.1056/NEJMoa1215372.
https://doi.org/10.1056/NEJMoa1215372
Kaplan A, Ledford D, Ashby M, Canvin J, Zazzali JL, Conner E, et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013;132(1):101-9. doi: 10.1016/j.jaci.2013.05.013.
https://doi.org/10.1016/j.jaci.2013.05.013
Sanclemente G, Burgos C, Nova J, Hernández F, González C, Reyes MI, et al. The impact of skin di¬seases on quality of life: A multicenter study. Actas Dermosifiliogr. 2017;108(3):244-52. doi: 10.1016/j.ad.2016.11.008.
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
